{
    "clinical_study": {
        "@rank": "67332", 
        "brief_summary": {
            "textblock": "To evaluate viral load in the blood stream of HIV-infected patients during a 28-day washout\n      following cessation of long-term zidovudine ( AZT ) therapy.\n\n      Because viral load (amount of HIV RNA in the plasma) is often used as a measure of the\n      effectiveness of new antiretroviral drugs in clinical trials, a washout period, or cessation\n      of current antiretroviral regimens, is commonly required for study entry to allow for a\n      drug-free steady state of viral load prior to initiation of the new drug. However, the\n      kinetics of the viral rebound following drug withdrawal has not been sufficiently studied,\n      and the proper duration of washout is an estimate."
        }, 
        "brief_title": "A Multicenter, Exploratory Study to Evaluate the Effects of Antiretroviral Cessation on Plasma Associated HIV-1 RNA", 
        "condition": "HIV Infections", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "Because viral load (amount of HIV RNA in the plasma) is often used as a measure of the\n      effectiveness of new antiretroviral drugs in clinical trials, a washout period, or cessation\n      of current antiretroviral regimens, is commonly required for study entry to allow for a\n      drug-free steady state of viral load prior to initiation of the new drug. However, the\n      kinetics of the viral rebound following drug withdrawal has not been sufficiently studied,\n      and the proper duration of washout is an estimate.\n\n      Patients who have volunteered to temporarily cease antiretroviral therapy will be followed\n      during a 28-day washout period. Blood samples are drawn at each of nine clinic visits.\n      Patients may resume antiretrovirals after the 28-day washout."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Concurrent Medication:\n\n        Allowed:\n\n          -  Maintenance therapy for opportunistic infection, provided patient has received at\n             least 1 month of stable therapy prior to study.\n\n          -  G-CSF.\n\n        Patients must have:\n\n          -  HIV infection.\n\n          -  CD4 count <= 500 cells/mm3.\n\n          -  At least 12 months of prior AZT, with 2 months of continuous AZT monotherapy\n             immediately prior to study.\n\n          -  The need to discontinue AZT because of drug-related toxicity or unwanted side effects\n             or as an entry requirement for another research study.\n\n          -  Consent of parent or guardian if < 18 years old.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following symptoms or conditions are excluded:\n\n          -  Current medical status that is considered unsuitable for study participation.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Therapy for an acute opportunistic infection.\n\n        Prior Medication:\n\n        Excluded within the past 2 months:\n\n          -  Antiretrovirals other than AZT.\n\n          -  Systemic immunomodulators (e.g., gp120, gp160, IL-2, and interferons).\n\n        Excluded within the past month:\n\n          -  Vaccination."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "13 Years"
        }, 
        "enrollment": "70", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000840", 
            "org_study_id": "ACTG 304"
        }, 
        "keyword": [
            "Acquired Immunodeficiency Syndrome", 
            "AIDS-Related Complex", 
            "Antiviral Agents", 
            "Zidovudine", 
            "Biological Markers", 
            "Viremia", 
            "RNA, Viral"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60611"
                    }, 
                    "name": "Northwestern Univ Med School"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60612"
                    }, 
                    "name": "Rush Presbyterian - Saint Luke's Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21287"
                    }, 
                    "name": "Johns Hopkins Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Buffalo", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14215"
                    }, 
                    "name": "SUNY / Erie County Med Ctr at Buffalo"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14642"
                    }, 
                    "name": "Univ of Rochester Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cleveland", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44106"
                    }, 
                    "name": "Case Western Reserve Univ"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "432101228"
                    }, 
                    "name": "Ohio State Univ Hosp Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "981224304"
                    }, 
                    "name": "Univ of Washington"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Multicenter, Exploratory Study to Evaluate the Effects of Antiretroviral Cessation on Plasma Associated HIV-1 RNA", 
        "overall_official": [
            {
                "last_name": "Para MF", 
                "role": "Study Chair"
            }, 
            {
                "last_name": "Demeter L", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000840"
        }, 
        "source": "National Institute of Allergy and Infectious Diseases (NIAID)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute of Allergy and Infectious Diseases (NIAID)", 
                "agency_class": "NIH"
            }
        }, 
        "study_design": "Observational Model: Natural History", 
        "study_type": "Observational", 
        "verification_date": "April 2000"
    }, 
    "geocoordinates": {
        "Case Western Reserve Univ": "41.499 -81.695", 
        "Johns Hopkins Hosp": "39.29 -76.612", 
        "Northwestern Univ Med School": "41.878 -87.63", 
        "Ohio State Univ Hosp Clinic": "39.961 -82.999", 
        "Rush Presbyterian - Saint Luke's Med Ctr": "41.878 -87.63", 
        "SUNY / Erie County Med Ctr at Buffalo": "42.886 -78.878", 
        "Univ of Rochester Medical Center": "43.161 -77.611", 
        "Univ of Washington": "47.606 -122.332"
    }
}